Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AMERICAN CRYOSTEM CORPORATION

(CRYO)
Delayed OTC Markets  -  03:40 2022-12-02 pm EST
0.1310 USD   -1.87%
08/22AMERICAN CRYOSTEM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS (form 10-Q)
AQ
08/22American CryoStem Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
05/23AMERICAN CRYOSTEM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATIONS (form 10-Q)
AQ
 SummaryQuotesChartsNewsCompanyFinancialsFunds 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
11/28/2022 11/29/2022 11/30/2022 12/01/2022 12/02/2022 Date
0.145(c) 0.14(c) 0.121(c) 0.1335(c) 0.131(c) Last
54 745 10 000 1 670 17 000 181 Volume
0.00% -3.45% -13.57% +10.33% -1.87% Change
More quotes
Estimated financial data (e) (USD)
Sales 2020 0,56 M - -
Net income 2020 -1,18 M - -
Net Debt 2020 0,91 M - -
P/E ratio 2020 -16,0x
Yield 2020 -
Sales 2021 0,02 M - -
Net income 2021 -2,88 M - -
Net Debt 2021 1,14 M - -
P/E ratio 2021 -6,29x
Yield 2021 -
Capitalization 5,84 M 5,84 M -
EV / Sales 2020 37,0x
EV / Sales 2021 937x
Nbr of Employees 4
Free-Float 45,0%
More Financials
Company
American CryoStem Corporation is a biotechnology company. The Company has developed adipose tissue-derived technologies (Adult Stem Cells) for the fields of regenerative and personalized medicine. Its technologies are the basis for the chemistry, manufacturing, and controls (cGMP Manufacturing) of its ATCell autologous cellular therapy product for use in clinical investigations for biologic license applications with... 
More about the company
All news about AMERICAN CRYOSTEM CORPORATION
08/22AMERICAN CRYOSTEM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
08/22American CryoStem Corporation Reports Earnings Results for the Third Quarter and Nine M..
CI
05/23AMERICAN CRYOSTEM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
05/23American CryoStem Corporation Reports Earnings Results for the Second Quarter and Six M..
CI
02/22AMERICAN CRYOSTEM CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
02/22American CryoStem Corporation Reports Earnings Results for the First Quarter Ended Dece..
CI
01/13AMERICAN CRYOSTEM CORP Management's Discussion and Analysis of Financial Condition and..
AQ
01/13American CryoStem Corporation Reports Earnings Results for the Full Year Ended Septembe..
CI
01/13American CryoStem Corporation Auditor Raises 'Going Concern' Doubt
CI
2021American Cryostem Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
AQ
2021American Cryostem : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN O..
AQ
2021American Cryostem Corporation Reports Earnings Results for the Third Quarter Ended June..
CI
2021American Cryostem : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN O..
AQ
2021American Cryostem Corporation Reports Earnings Results for the Second Quarter Ended Mar..
CI
2021American Cryostem : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN O..
AQ
More news
News in other languages on AMERICAN CRYOSTEM CORPORATION
08/22American CryoStem Corporation annonce ses résultats pour le troisième trimestre et les ..
05/23American CryoStem Corporation annonce ses résultats pour le deuxième trimestre et les s..
02/22American CryoStem Corporation annonce ses résultats pour le premier trimestre se termin..
01/13American CryoStem Corporation annonce ses résultats pour l'exercice complet terminé le ..
01/13L'auditeur d'American CryoStem Corporation soulève un doute sur la pérennité de l'entre..
More news
Chart AMERICAN CRYOSTEM CORPORATION
Duration : Period :
American CryoStem Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
John S. Arnone Chairman
Anthony Francis Dudzinski COO, Secretary, Treasurer & Director
John DiFolco Director-Marketing
Ruth Goldman Vice President & Laboratory Director
Sector and Competitors
1st jan.Capi. (M$)
AMERICAN CRYOSTEM CORPORATION-80.93%6
MODERNA, INC.-28.55%67 581
IQVIA HOLDINGS INC.-22.83%40 495
LONZA GROUP AG-33.17%38 281
ALNYLAM PHARMACEUTICALS, INC.38.22%27 139
SEAGEN INC.-20.82%22 538